News | Brachytherapy Systems | January 16, 2017

Radiation Oncology Centres Launches Australia’s First Electronic Brachytherapy System for Treating Skin Cancer

Esteya system by Elekta providing patients in Australia and New Zealand with a new, gentle treatment option

Elekta, Esteya electronic brachytherapy system, Radiation Oncology Centres, first in Australia, skin cancer

January 16, 2017 — On Dec. 8, 2016, a female patient in her 60s became the first in the Australia/New Zealand region to receive electronic brachytherapy to treat her skin cancer lesion, a basal cell carcinoma on her nose. Radiation Oncology Centres (ROC) physicians in Brisbane used their new Esteya electronic brachytherapy system from Elekta to deliver the patient’s first of six non-invasive treatments. Esteya is a form of high dose rate (HDR) brachytherapy that applies high-precision radiation therapy directly to the cancer site, reducing radiation to surrounding healthy tissues.

“This first treatment took just 2.5 minutes and the patient tolerated the procedure very well,” said Mike Poulsen, M.D., radiation oncologist at ROC. “She will have just five more therapy visits to complete the treatment, a much quicker course than conventional radiotherapy.”

ROC, part of the Icon Group, is Queensland’s largest provider of radiation therapy services and among Australia’s fastest growing. ROC acquired Esteya in October and the center’s clinicians have been eager to put the system to use in a region with the world’s highest incidence of skin cancer.

“Non-melanoma skin cancers are the most common cancers in Australia and skin cancers account for around 80 percent of newly diagnosed cancers in the country,” Poulsen noted. “About two in three Australians will be diagnosed with skin cancer by the time they are 70, with more than 750,000 people treated for one or more non-melanoma skin cancers in Australia each year. In Queensland alone, over 350,000 non-melanoma skin cancers are treated annually, so the need for skin cancer treatments is great.”

According to Poulsen, Esteya gives suitable patients a good alternative to surgery.

“Our current radiation treatment for skin cancers uses electrons generated from a linear accelerator. While this treatment is very effective for larger skin cancers, it is not ideal for small, superficial lesion,” he explained. “This is where Esteya will be very useful to treat early skin cancers. The advantage of Esteya is that it uses very low energy X-rays, allowing more of the surrounding tissues to avoid unnecessary radiation. The advanced integrated Esteya software also makes treatment delivery extremely safe.”

Esteya treatments are usually given over six to 10 treatment sessions divided over 2-3 times per week, each session lasting just a few minutes. The treatment is typically painless and well tolerated.

In addition to practical reasons such as lesion size, many non-melanoma skin cancer patients may wish to avoid surgery for medical or cosmetic reasons. Esteya provides these patients with an attractive alternative, Poulsen added.

“Ideal candidates for Esteya treatment are older patients, a population in which skin cancers are common,” Poulsen added. “The treatment may also be used for high-risk skin cancers post-surgically to reduce the risk of recurrence locally. This may allow the patient to avoid re-excision of the lesion.”

Another critical advantage of Esteya for the multi-center ROC is the system’s compact size.

“Esteya is extremely compact and portable,” he noted. “This has the potential for the machine to be moved to some of our regional centers, which currently aren’t able to access superficial radiation treatment.”

For more information: www.esteya.com

Related Content

New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
The novel nanoparticle is designed to enhance radiation killing of cancer cells in the radiation resistant low-oxygen tumor core

The novel nanoparticle is designed to enhance radiation killing of cancer cells in the radiation resistant low-oxygen tumor core. Credit: Wenpei Fan, LOMIN Laboratory, NIBIB.

News | Radiation Therapy | May 08, 2019
Radiation kills tumors by creating oxygen free radicals that damage the tumor DNA. However, the lack of oxygen in the...
Netherlands Proton Therapy Center Delivers First Clinical Flash Irradiation
News | Proton Therapy | May 02, 2019
IBA (Ion Beam Applications SA) recently announced the first Flash irradiation in an IBA proton therapy gantry treatment...
Artificial intelligence (AI) was again the hottest topic in radiology, with 11 of the top 20 pieces of content this month relating to AI. These images are a few of the AI technologies highlighted in ITN Editor's Choice video of the most innovative AI technologies highlighted at RSNA 2018.

Artificial intelligence (AI) was again the hottest topic in radiology, with 11 of the top 20 pieces of content this month relating to AI. These images are a few of the AI technologies highlighted in ITN Editor's Choice video of the most innovative AI technologies highlighted at RSNA 2018. 

Feature | May 01, 2019
May 1, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine webs
Pencil Beam Scanning Better Protects Children With Brain Tumors
News | Proton Therapy | May 01, 2019
A comparison of three types of radiotherapy for children's brain tumors suggests a type of proton therapy called pencil...
Researchers Identify Ways to Predict and Avoid Radiotherapy Side Effects
News | Radiation Therapy | April 30, 2019
New research has shown a combination of biological markers and certain genetic changes can predict radiation...